Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s stock price dropped 1.2% on Thursday . The stock traded as low as $3.6750 and last traded at $3.6750. Approximately 7,960 shares traded hands during mid-day trading, a decline of 40% from the average session volume of 13,304 shares. The stock had previously closed at $3.72.
Medexus Pharmaceuticals Price Performance
The business’s 50-day simple moving average is $3.53 and its two-hundred day simple moving average is $2.92.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
- MarketBeat Week in Review – 08/24 – 08/28
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
